As we look towards the future of the role of the perfusionist, Medtronic is of the opinion that the perfusionist’s role and the accompanying technology need to develop along with the therapies outside cardiac surgery to enable the perfusionist in the current role to become more of an extracorporeal specialist beyond support in the cardiac theatre. We will present our view of the future and the role innovation has had thus far within the Medtronic portfolio as well as where technology development might take us in the future, looking at the needs of the patient and the needs of the clinician in terms of safety, data management, patient monitoring, and of course from a regulatory perspective. The latter cannot be understated as the regulations continue to evolve locally in the UK in a manner somewhat in parallel with the Medical Device Requirements in the European Union.
Mike is a mechanical engineer by trade, with a Masters of Science and Bachelors in Economics from Harvey Mudd College, located in Mike's home town of Los Angeles, CA. He has over thirty years' experience in extracorporeal therapies technology, entering the field in 1989 as an engineering intern. Mike has been the Business Director of Medtronic International Extracorporeal Therapies since 2008 for the region of Europe, Middle East, Africa and supports the Canadian and Australia/New Zealand cardiac surgery marketing teams as well. Mike and his wife have resided in Italy since 1999, in the town of Mirandola, one of the primary biomechanical engineering/technology development centers in the world.